Anticonvulsant activity of Mimosa pudica decoction

Fitoterapia

Volumn 75, Issue 3-4, 2004, Pages 309-314

  Ngo Bum, E ^a   Dawack, D L ^a   Schmutz, M ^b   Rakotonirina, A ^c   Rakotonirina, S V ^c   Portet, C ^b   Jeker, A ^b   Olpe, H R ^b   Herrling, P ^b  

^a UNIVERSITÉ DE NGAOUNDÉRÉ   (Cameroon)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF YAOUNDÉ I   (Cameroon)

Author keywords

Anticonvulsant; Mimosa pudica; Sedative; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; HERBACEOUS AGENT; MIMOSA PUDICA EXTRACT; N METHYL DEXTRO ASPARTIC ACID; PENTYLENTETRAZOL; PICROTOXIN; PLANT EXTRACT; STRYCHNINE; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; MALE; MEDICINAL PLANT; MIMOSA; MIMOSA PUDICA; MOUSE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTECTION; SEIZURE;

ANIMALS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRAPERITONEAL; MALE; MEDICINE, AFRICAN TRADITIONAL; MICE; MIMOSA; PENTYLENETETRAZOLE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; SEIZURES; STRYCHNINE;

MIMOSA; MIMOSA PUDICA; STRYCHNOS TOXIFERA;

EID: 2442698646     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2004.01.012     Document Type: Article

References (14)

1. Hutchinson J, Dalziel JM. The flora of West Tropical Africa. Crown Agents for Overseas Governments and Administration, 1958
2. Morton J.F. Atlas of medicinal plants of Middle America, Bahamas to Yucatan. 1981;Thomas Spring-field
3. Walker RA, Sillans R. Les plantes utiles du Gabon. Edition Paul le Chevalier, 1961
4. Amalraj T., Ignacimuthu S. Fitoterapia. 73:2002;351
5. Berhaut J. Flore illustrée du Senegal. Dicotylédones. Tome IV: Ficoidées à Legumineuses. Government of Senegal, 1975
6. Lehmann J., Hutchison A., McPherson S.E., Mondadori C., Schmutz M., Sinton C.M., Tsai C., Murphy D.E., Steel D.J., Williams M., Cheng D.L., Wood P.L. J Pharmacol Exp Ther. 246:1988;65
7. Ngo Bum E., Schmutz M., Meyer C., Rakotonirina A., Bopelet M., Portet C., Jeker A., Rakotonirina S.U., Olpe H.R., Herrling P. J Ethnopharmacol. 76:2001;145
8. Schmutz M., Portet C., Jeker A., Klebs K., Vassout A., Allgeier H., Heckendorn R., Fagg G.E., Olpe H.R., Van Riezen H. Naunyn Schmiedeberg's. Arch Pharmacol. 342:1990;61
9. Kupferberg H.J., Schmutz M. Engel J., Pedley T.A. Screening of new compounds and the role of the pharmaceutical industry. 1998;Lippincott-Raven, Philadelphia, New York
10. Rogawski M.A., Porter R.J. Pharmacol Rev. 42:1990;223
11. De Deyn P.P., D'Hooge R., Marescau B., Pei Y.-Q. Epilepsy Res. 12:1992;87
12. Löscher W., Schmidt D. Epilepsy Res. 2:1988;145
13. Doctor S.V., Costa L.G., Murphy S.D. Toxicol Lett. 13:1982;217
14. Findlay G.S., Wick M.J., Mascia M.P., Wallace D., Millier G.W., Harris R.A., Blednov Y.A. JPET. 300:2002;526